Quantitative Investment Management, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
Quantitative Investment Management, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$1,408,000
+82.6%
90,260
+4.8%
0.11%
+44.3%
Q2 2020$771,000
-3.7%
86,145
+2.6%
0.08%
+71.7%
Q1 2019$801,000
+333.0%
84,000
+418.5%
0.05%
+360.0%
Q4 2018$185,000
-70.6%
16,200
-56.5%
0.01%
-54.5%
Q3 2018$630,000
+148.0%
37,200
-17.5%
0.02%
+15.8%
Q3 2015$254,000
+29.6%
45,100
+249.6%
0.02%
-45.7%
Q2 2014$196,000
-81.1%
12,900
-77.5%
0.04%
-28.6%
Q1 2014$1,035,00057,3000.05%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders